| Rupatadine |
20130385 |
Rupafin, Tablet, 10, mg, Pack: 30 |
J. Uriach & Cia., S.A., Испания |
J. Uriach & Cia., S. A., Испания |
11.15 |
2.23 |
13.38 |
6% |
0.67 |
11.82 |
2.36 |
14.18 |
18% |
2.01 |
13.83 |
2.77 |
16.6 |
НСР-10340/15.09.2016 |
02.10.2016 |
02.10.2016 |
|
|
Активен |
15377 |
| Midostaurin |
EU/1/17/1218/001 |
Rydapt, Capsule, soft, 25, mg, Pack: 112 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
26182.29 |
5236.46 |
31418.75 |
4% |
10 |
26192.29 |
5238.46 |
31430.75 |
16% |
25 |
26217.29 |
5243.46 |
31460.75 |
НСР-15511/26.04.2018 |
11.05.2018 |
02.09.2018 |
Промяна на обстоятелствата НСР-16378/02.08.2018 |
|
Активен |
16111 |
| Midostaurin |
EU/1/17/1218/001 |
Rydapt, Capsule, soft, 25, mg, Pack: 112 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
26182.29 |
5236.46 |
31418.75 |
4% |
10 |
26192.29 |
5238.46 |
31430.75 |
16% |
25 |
26217.29 |
5243.46 |
31460.75 |
НСР-15511/26.04.2018 |
11.05.2018 |
02.06.2018 |
|
|
Неактивен |
16111 |
| Propafenone |
ІІ-9258/01.07.2004 г. |
RYTMOCARD, Solution for injection, 35 mg/10 ml -10 ml, -, Pack: 5 |
Софарма АД, България |
СОФАРМА АД |
6.5 |
1.3 |
7.8 |
7% |
0.45 |
6.95 |
1.39 |
8.34 |
20% |
1.3 |
8.25 |
1.65 |
9.9 |
КЦ-53/
24,04,2008 г. |
28.05.2008 |
28.05.2008 |
|
|
Активен |
7664 |
| Propafenone |
ІІ-9258/01.07.2004 г. |
RYTMOCARD, sol. Inj, 35 mg/10 ml -10 ml, -, Pack: 5 |
Софарма АД, България |
СОФАРМА АД |
6.5 |
1.3 |
7.8 |
7% |
0.46 |
6.96 |
1.39 |
8.35 |
20% |
1.3 |
8.26 |
1.65 |
9.91 |
КЦ-53/
24,04,2008 г. |
28.05.2008 |
28.05.2008 |
|
|
Неактивен |
7664 |
| Propafenone |
ІІ-9258/01.07.2004 г. |
RYTMOCARD, Solution for injection, 35 mg/10 ml -10 ml, -, Pack: 50 |
Софарма АД, България |
СОФАРМА АД |
65 |
13 |
78 |
4% |
2.6 |
67.6 |
13.52 |
81.12 |
16% |
10.4 |
78 |
15.6 |
93.6 |
КЦ-53/
24,04,2008 г. |
28.05.2008 |
28.05.2008 |
|
|
Активен |
7665 |
| Propafenone |
ІІ-9258/01.07.2004 г. |
RYTMOCARD, sol. Inj, 35 mg/10 ml -10 ml, -, Pack: 50 |
Софарма АД, България |
СОФАРМА АД |
65 |
13 |
78 |
4% |
2.6 |
67.6 |
13.52 |
81.12 |
16% |
10.4 |
78 |
15.6 |
93.6 |
КЦ-53/
24,04,2008 г. |
28.05.2008 |
28.05.2008 |
|
|
Неактивен |
7665 |
| Propafenone |
II-0944/24.10.2007 |
RYTMONORM, Solution for injection, 70mg/20ml, -, Pack: 5 |
Abbott GmbH & Co KG, Германия |
EBEWE Pharma Ges.m.b.H N fg. KG - Австрия |
3.7 |
0.74 |
4.44 |
7% |
0.26 |
3.96 |
0.79 |
4.75 |
20% |
0.74 |
4.7 |
0.94 |
5.64 |
КЦ-452/
21,01,2009 г. |
14.02.2009 |
14.02.2009 |
пределната цена е заличена с решение НСР-7886/25.01.2016 |
|
Заличен |
7666 |
| Salbutamol |
II-13613/22.06.2006 г. |
SALBUTAMOL SOPHARMA, syr., 2 mg/5 ml - 125 ml, -, Pack: 1 |
Софарма АД, България |
СОФАРМА АД |
2.1 |
0.42 |
2.52 |
7% |
0.15 |
2.25 |
0.45 |
2.7 |
20% |
0.42 |
2.67 |
0.53 |
3.2 |
КЦ-53/
24,04,2008 г. |
28.05.2008 |
28.05.2008 |
|
|
Активен |
7733 |
| Salbutamol |
II-13128 / 02.05.2011 |
Salbutamol WZF, Tablet, 4 mg, -, Pack: 25 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
2.52 |
0.5 |
3.02 |
7% |
0.18 |
2.7 |
0.54 |
3.24 |
20% |
0.5 |
3.2 |
0.64 |
3.84 |
КЦ-2691/13.09.2011 г.; НСР-1415/10.10.2013 |
29.10.2013 |
02.09.2018 |
корекц. решение НСР-16234/19.07.2018 |
|
Активен |
7739 |
| Salbutamol |
9900343 |
Salbutamol WZF, Tablet, 2 mg, -, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Poland |
2.19 |
0.44 |
2.63 |
7% |
0.15 |
2.34 |
0.47 |
2.81 |
20% |
0.44 |
2.78 |
0.56 |
3.34 |
НСР-1415/10.10.2013 |
29.10.2013 |
02.09.2018 |
корекц. решение НСР-16234/19.07.2018 |
|
Активен |
8469 |
| Salbutamol |
№ II - 13128 / 02.05.2011 |
Salbutamol WZF, Tablet, 4 mg, -, Pack: 25 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
2.44 |
0.49 |
2.93 |
7% |
0.17 |
2.61 |
0.52 |
3.13 |
20% |
0.49 |
3.1 |
0.62 |
3.72 |
КЦ-2691/13.09.2011 г. |
28.09.2011 |
28.09.2011 |
|
|
Неактивен |
7739 |
| Salbutamol |
9900343 |
Salbutamol WZF, Tablet, 2 mg, -, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Poland |
2.19 |
0.44 |
2.63 |
7% |
0.15 |
2.34 |
0.47 |
2.81 |
20% |
0.44 |
2.78 |
0.56 |
3.34 |
НСР-1415/10.10.2013 |
29.10.2013 |
29.10.2013 |
|
|
Неактивен |
8469 |
| Salbutamol |
12070/28.12.2005 г. |
SALBUTAMOL WZF, Tablet, 2 mg, -, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Poland |
2.01 |
0.4 |
2.41 |
7% |
0.14 |
2.15 |
0.43 |
2.58 |
20% |
0.4 |
2.55 |
0.51 |
3.06 |
КЦ-431/16.01.2009 г.; корек.решение НСР-16234/19.07.2018 |
14.02.2009 |
02.09.2018 |
|
|
Заличен |
7735 |
| Salbutamol |
12070/28.12.2005 г. |
SALBUTAMOL WZF, Tablet, 2 mg, -, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Poland |
2.01 |
0.4 |
2.41 |
7% |
0.14 |
2.15 |
0.43 |
2.58 |
20% |
0.4 |
2.55 |
0.51 |
3.06 |
КЦ-431/
16,01,2009 г. |
14.02.2009 |
14.02.2009 |
|
|
Неактивен |
7735 |
| Salbutamol |
12071/28.12.2005 г. |
SALBUTAMOL WZF, Tablet, 4 mg, -, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Poland |
2.74 |
0.55 |
3.29 |
7% |
0.19 |
2.93 |
0.59 |
3.52 |
20% |
0.55 |
3.48 |
0.7 |
4.18 |
КЦ-431/
16,01,2009 г. |
14.02.2009 |
14.02.2009 |
|
|
Активен |
7736 |
| Mesalazine |
9600114 |
SALOFALK, Gastro resistant tablet, 250, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
17.5 |
3.5 |
21 |
6% |
1.05 |
18.55 |
3.71 |
22.26 |
18% |
3.15 |
21.7 |
4.34 |
26.04 |
НСР-9323/16.05.2016; НСР-17000/12.10.2018 |
02.07.2016 |
02.11.2018 |
|
|
Заличен |
15083 |
| Mesalazine |
9600114 |
SALOFALK, Gastro resistant tablet, 250, mg, Pack: 100 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH, Германия |
17.5 |
3.5 |
21 |
6% |
1.05 |
18.55 |
3.71 |
22.26 |
18% |
3.15 |
21.7 |
4.34 |
26.04 |
НСР-9323/16.05.2016 |
02.07.2016 |
02.07.2016 |
|
|
Неактивен |
15083 |
| Mesalazine |
9600068 |
SALOFALK, Suppository, 500, mg, Pack: 30 |
Dr. Falk Pharma GmbH, Германия |
Dr Falk Pharma GmbH, Germany |
30.61 |
6.12 |
36.73 |
4% |
1.22 |
31.83 |
6.37 |
38.2 |
16% |
4.9 |
36.73 |
7.35 |
44.08 |
НСР-9075/21.04.2016 |
02.06.2016 |
02.06.2016 |
|
|
Активен |
15021 |
| Liraglutide |
EU/1/15/992/002 |
Saxenda, Solution for injection, 6 mg/ml-3 ml, -, Pack: 3 pre-filled pens |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S, Дания |
259.64 |
51.93 |
311.57 |
4% |
10 |
269.64 |
53.93 |
323.57 |
16% |
25 |
294.64 |
58.93 |
353.57 |
НСР-16590/24.08.2018 |
08.09.2018 |
02.10.2018 |
|
|
Активен |
16248 |
| Mepivacaine |
9900158/05.10.2004 |
Scandonest, Solution for injection, 30mg/ml, -, Pack: |
Septodonte, Франция |
Septodont, France |
26.48 |
5.3 |
31.78 |
6% |
1.59 |
28.07 |
5.61 |
33.68 |
18% |
4.77 |
32.84 |
6.57 |
39.41 |
НСР-1771/21.11.2013 |
20.12.2013 |
20.12.2013 |
|
|
Активен |
8630 |
| Mepivacaine, combinations |
9900007 |
Scandonest, Solution for injection, 2% Special with adrenaline 1:100000, -, Pack: |
Septodonte, Франция |
Septodont, France |
26.48 |
5.3 |
31.78 |
6% |
1.59 |
28.07 |
5.61 |
33.68 |
18% |
4.77 |
32.84 |
6.57 |
39.41 |
НСР-1771/21.11.2013 |
20.12.2013 |
20.12.2013 |
|
|
Активен |
8631 |
| Iopamidol |
20050027 |
SCANLUX 300, Solution for injection, 300 mg I/ ml - 50 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Sanochemia Pharmazeutika AG, Austria |
252.07 |
50.41 |
302.48 |
4% |
10 |
262.07 |
52.41 |
314.48 |
16% |
25 |
287.07 |
57.41 |
344.48 |
НСР-11979/10.03.2017 г. |
02.04.2017 |
02.04.2017 |
|
|
Активен |
806 |
| Iopamidol |
20020027 |
SCANLUX 300, Solution for injection, 300 mg I/ ml - 100 ml, mg, Pack: 10 |
Sanochemia Pharmazeutika AG, Австрия |
Sanochemia Pharmazeutika AG, Austria |
493.65 |
98.73 |
592.38 |
4% |
10 |
503.65 |
100.73 |
604.38 |
16% |
25 |
528.65 |
105.73 |
634.38 |
НСР-11980/10.03.2017 |
02.04.2017 |
02.04.2017 |
|
|
Активен |
2177 |
| Paracetamol, Phenobarbital, Metamizol, Caffeine, Codeine |
20030050 |
Sedalgin - neo, Tablet, 300 mg/15 mg/150 mg/50 mg/10 mg, -, Pack: 20 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.72 |
0.54 |
3.26 |
7% |
0.19 |
2.91 |
0.58 |
3.49 |
20% |
0.54 |
3.45 |
0.69 |
4.14 |
НСР-6014/09.04.2015.; НСР-12292/07.04.2017 |
23.04.2015 |
02.05.2017 |
протокол 217/30.03.2017 |
|
Заличен |
7982 |